⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Diisopropanolamine SCHEMBL22774 | 0.81 | — | — | |
| Diisopropanolamine SCHEMBL10618901 | 0.81 | — | — | |
| Diisopropanolamine SCHEMBL7592152 | 0.78 | TSHR (0.41) | — | |
| Diisopropanolamine SCHEMBL3362609 | 0.78 | ALDH1A1 (0.43) | — | |
| Diisopropanolamine SCHEMBL6858463 | 0.78 | TSHR (0.41) | — | |
| Diisopropanolamine SCHEMBL28590399 | 0.78 | TSHR (0.41) | — | |
| Diisopropanolamine SCHEMBL839563 | 0.78 | TSHR (0.41) | — | |
| SCHEMBL727619 | 0.75 | KMT2A (0.47) | — | |
| SCHEMBL367291 | 0.75 | — | — | |
| SCHEMBL11501652 | 0.75 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 43 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-107973788-B | BBI608 derivative and preparation and application thereof | 沈阳药科大学 | 2021-07-09 | — | — | CN | claimed |
| US-20060147498-A1 | Composition material for transmucosal delivery | MAGLE HOLDING AB (SE) | 2006-07-06 | — | — | US | claimed |
| US-20060074105-A1 | Substituted quinoline and quinazoline inhibitors of quinone reductase 2 | SERENEX, INC. (US) | 2006-04-06 | — | — | US | claimed |
| WO-2006034235-A2 | SUBSTITUTED QUINOLINE AND QUINAZOLINE INHIBITORS OF QUINONE REDUCTASE 2 | SERENEX, INC. (US) | 2006-03-30 | — | — | WO | claimed |
| US-4650909-A | PURIFICATION BY ION EXCHANGE | YOAKUM GEORGE H | 1987-03-17 | — | — | US | claimed |
| EP-0077826-A4 | AGENTS FOR ARRESTING FULMINATING INFECTION. | EVREKA INC (US) | 1984-01-16 | — | — | EP | claimed |
| EP-0077826-A1 | AGENTS FOR ARRESTING FULMINATING INFECTION. | EVREKA INC (US) | 1983-05-04 | — | — | EP | claimed |
| WO-1982003770-A1 | METHOD AND AGENTS FOR ARRESTING FULMINATING INFECTION | EVREKA INC (US) | 1982-11-11 | — | — | WO | claimed |
| US-4286067-A | Article of manufacture comprising semipermeable polymer and dextran derivative | ALZA CORPORATION (US) | 1981-08-25 | — | — | US | claimed |
| CN-107973788-B | BBI608 derivative and preparation and application thereof | 沈阳药科大学 | 2021-07-09 | — | — | CN | disclosed |
| CN-112996789-A | Antiviral pyridopyrazinedione compounds | 诺华股份有限公司 | 2021-06-18 | — | — | CN | disclosed |
| US-9752192-B2 | Compositions and methods for diagnosing autism | RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY (US) | 2017-09-05 | — | — | US | disclosed |
| US-20130183669-A1 | COMPOSITIONS AND METHODS FOR DIAGNOSING AUTISM | RUTGERS, THE STATE UNIVERSITY (US) | 2013-07-18 | — | — | US | disclosed |
| US-20100330113-A1 | Vaccine Antigens | INTERVET INTERNATIONAL B.V. | 2010-12-30 | — | — | US | disclosed |
| US-20030082173-A1 | Lymphocyte surface receptor that binds CAML and methods of use thereof | ST. JUDE CHILDREN'S RESEARCH HOSPITAL, INC. | 2003-05-01 | — | — | US | disclosed |
| US-20020197690-A1 | GNK interacting amino acid decarboxylase and methods of use thereof | IMMUNEX CORPORATION | 2002-12-26 | — | — | US | disclosed |
| EP-0362283-A4 | BOVINE INTERLEUKIN-1_G(A) | — | 1991-10-16 | — | — | EP | disclosed |
| EP-0362283-A1 | BOVINE INTERLEUKIN-1 ALPHA. | IMMUNEX CORP (US) | 1990-04-11 | — | — | EP | disclosed |
| WO-1988009382-A1 | BOVINE INTERLEUKIN-1alpha | IMMUNEX CORPORATION (US) | 1988-12-01 | — | — | WO | disclosed |
| EP-0289129-A2 | High purity protein A preparation | REPLIGEN CORPORATION (US) | 1988-11-02 | — | — | EP | disclosed |